Otsuka Holdings Co Ltd released its earnings results on Oct 31, 2025. The company reported $0.762 earnings per share for the quarter, beating the consensus estimate of $0.515 by $0.247.

Is Otsuka Holdings Co Ltd overvalued?

According to Wall Street analysts Otsuka Holdings Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Otsuka Holdings Co Ltd pay dividends?

Otsuka Holdings Co Ltd pays a Semiannually dividend of $0.235 which represents an annual dividend yield of 1.48%. See more information on Otsuka Holdings Co Ltd dividends here

What is Otsuka Holdings Co Ltd’s EPS estimate?

Otsuka Holdings Co Ltd’s EPS estimate is 0.22.

How many shares outstanding does Otsuka Holdings Co Ltd have?

Otsuka Holdings Co Ltd has 1,085,977,800 shares outstanding.

What happened to Otsuka Holdings Co Ltd’s price movement after its last earnings report?

Otsuka Holdings Co Ltd reported an EPS of $0.762 in its last earnings report, beating expectations of $0.515. Following the earnings report the stock price went up 1.173%.

Which hedge fund is a major shareholder of Otsuka Holdings Co Ltd?

Currently, no hedge funds are holding shares in OTSKY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Otsuka Holdings Co Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

15.51%

Trailing 12-Months

Asset Growth

15.28%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Otsuka Holdings Co Ltd

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.